COPD treatment study based on eosinophil levels
Treatments studied
Part of Lungs & breathing clinical trials.
This trial tests if inhaled corticosteroids (ICS) work better for COPD patients with different eosinophil levels. You must already be taking two long-acting bronchodilators and have stopped smoking for at least 6 months.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 40 years or older.
- You have smoked at least 10 pack-years (e.g., 1 pack a day for 10 years) and quit smoking more than 6 months ago.
- Your lung function shows COPD (FEV1/FVC less than 0.70) with mild to moderate airflow limitation (FEV1 at least 30% of normal).
- You are currently on two long-acting bronchodilator inhalers (LABA and LAMA) for at least 8 weeks.
- You have not used any inhaled steroid (ICS) in the last 3 months.
- You have not had a COPD flare-up (exacerbation) in the past 8 weeks.
- You do not have asthma, bronchiectasis, or other significant lung disease.
- You are not pregnant, breastfeeding, or planning to become pregnant, and if you can become pregnant, you agree to use highly effective contraception.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a triple-combination inhaler (budesonide, glycopyrronium, formoterol) against a placebo inhaler to see how it affects your heart and lungs if you have COPD and over-inflated lungs.
This trial tests a new medicine called lunsekimig for people with COPD that still causes flare-ups despite standard treatment. It focuses on people with higher blood eosinophils (a type of white blood cell). If you smoke or used to smoke and have had at least 2 moderate or 1 severe flare-up in the past year, this study may be an option.
This study tests a new medicine called Lunsekimig for people with COPD that has frequent flare-ups and high eosinophil levels (a sign of inflammation). It aims to see if it can help control symptoms better than a placebo (a dummy treatment).
This study looks at how well different biologic treatments work for people with severe or mild-to-moderate asthma, and compares them to healthy volunteers. It aims to find which treatments work best for different asthma types.
This study tests whether adding an immune-modulating tablet (made from bacteria) to a standard combination inhaler for asthma improves asthma control more than the inhaler alone. The study aims to see if this combination helps reduce symptoms and lung inflammation.
This study looks at how the immune system works and how well diseases like asthma, COPD, and others are controlled. You may join if you have one of these conditions or if you are a healthy volunteer or smoker without lung disease.
Hear when a new Chronic Obstructive Pulmonary Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.